Literature DB >> 8963950

Ontogenic development of drug-metabolizing enzymes in male chicken liver.

M Coulet1, C Eeckhoutte, P Galtier.   

Abstract

The ontogenic study of the hepatic biotransformation enzymes revealed the early development of both oxidative and conjugative enzymes in male chickens ranging in age from 3 to 12 weeks. Although the rate of microsomal cytochrome P450 reactions progressively increased during the first 9 weeks, it decreased thereafter. Furthermore, the proteins revealed by the antibodies to anti-cytochrome P450 1A2, 2B4, 2C7, and 3A4 appeared to be constitutively expressed. Hepatic monooxygenases were characterized by different developmental patterns. The demethylase activities increased progressively up to 9 weeks, then they declined, in 12 weeks reaching the activity level observed in 3-week-old chickens. In contrast, alkoxyresorufin O-dealkylases and benzopyrene hydroxylase activities continued to increase with age. Significant variability was noted for aniline hydroxylase. Among conjugation enzymes, UDP-glucuronyltransferase towards p-nitrophenol and isoniazid N-acetyltransferase activities increased with the age of the fowl, but with different profiles. Concerning glutathione S-transferase accepting 1-chloro-2,4-dinitrobenzene or 1,2-dichloro-4-nitrobenzene, the chickens aged from 3 to 9 weeks were less well developed in this enzyme than 12-week-old ones.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8963950

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  2 in total

1.  Lack of sex-influence on the in vitro metabolism of ivermectin by hepatic microsomal preparations from cattle.

Authors:  J Dupuy; C Eeckhoutte; J F Sutra; C Mage; M Alvinerie
Journal:  Vet Res Commun       Date:  1999-06       Impact factor: 2.459

2.  Comparison of hydrolytic and conjugative biotransformation pathways in horse, cattle, pig, broiler chick, rabbit and rat liver subcellullar fractions.

Authors:  F Gusson; M Carletti; A Giuliano Albo; M Dacasto; C Nebbia
Journal:  Vet Res Commun       Date:  2006-04       Impact factor: 2.459

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.